Ovarian Cancer Clincal Consult | Topics

 
Ovarian Cancer: Frontline Therapy
April 01, 2021

Dr. Rebecca Previs from the Duke Cancer Center reviews frontline therapy options for patients with advanced ovarian cancer.

Using PARP Inhibitors in Frontline Maintenance Therapy of Ovarian Cancer
January 20, 2021

Thomas Herzog, MD, provides insight on key clinical trials and the use of PARP inhibition in frontline maintenance therapy for ovarian cancer.

Using PARP Inhibitors in Frontline Maintenance Therapy for Ovarian Cancer
October 09, 2020

The use of PARP inhibitors in frontline maintenance therapy has greatly reduced the risk of recurrence in patients with ovarian cancer.